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A rapid method for simultaneous preparation of cytosol and nuclear estrogen (E) and progestin (P) receptors and their in vitro determination is described.
The method was applied to several uterine or ovarian surgical specimens to evaluate their steroid hormone "dependence".
The results suggest that low cytoplasmic E receptor levels (ERc) are associated with higher nuclear E receptor (ERn) levels but no apparent correlation was observed between PRc and ERn levels. The method appeared to be suitable for screening steroid hormone receptor content in tumor tissues and may provide better estimation of steroid dependence since boh cytoplasmic and nuclear compartments can be studied simultaneously.
Estrogen
is known to promote cell growth in its target tissues through interaction with specific, high-affinity protein receptor molecules. Growth stimulation by estrogen has been suggested to play an important role in the proliferation of tumors which contain estrogen receptors" and the quantitation of estrogen receptors in surgical specimens of gynecologic malignancy has been practiced to develop a possible use of estrogen antagonists such as tamoxifen (TMX) as an antineoplastic agent. 20, 21Up to the present time, the majority of studies of gynocologic malignancies have employed measurements of cytoplasmic estrogen receptors. Since cellular response to estrogenic stimulation is expressed through effects at the nuclear level, nuclear estrogen receptor levels would seem to more directly indicate the tissue responsiveness to estrogen. In the present study, we intended to develop a rapid in vitro method to measure both cytoplasmic and nuclear steroid receptors simultaneously in samples of human gynecologic malignancy. 
Results
Characterization of the Receptor Assay Cytosol and nuclear extract prepared separately21as well as prepared by the above described method were assayed for total, ERc, ERn and PRn by Scatchard analysis. The receptor binding affinity and capacity in cytosol and nuclei from one patient are shown in Fig.1 .
The dissociation constants (Kd) for estradiol and R5020in cytosol were0.1nM and3.5 nM and the binding capacity in the cytosol for estradiol and R5020was7.1and 120.6fmol/mg protein and that in the nuclear extract was362.1and213.6fmol/mg DNA. These values for Kd are essentially equal to the values obtained from cytosol and nuclear extracts prepared separately by the previous method.21The cell nuclear pellets appeared to be free of contamination by cell debris when observed with the electron microscope. the unoccupied estrogen receptors with 3H-estradiol in a dose dependent manner and the apparent ED50for the cytoplasmic receptors was4.5nM (Fig.4) .
Relationship between Estrogen and Progestin
Receptor concentrations There was no apparent correlation observed between any two combinations of cytoplasmic or nuclear estrogen and progestin receptor levels. Interestingly, however, when all receptor positive samples were divided into two arbitrary groups with low (less than10fmoles/mg protein) or high (greater than10fmoles/mg protein cytoplasmic estrogen receptor concentrations, the tissue nuclear receptor levels appeared to be greater in the former group (0.01< p<0.05, Fig.5 reproductive tissues have been studied for their possible "dependence" on estrogen by in vitro measurement of putative cytoplasmic estrogen recepters. 7-9, 20, 21, 24 Recently, however, it has been suggested that cell estrogen receptors reside predominantly in the cell nucleus and not in the cytoplasm in vivo. 10, 25 This agrees with the observation that uterine growth or RNA polymerase activities induced after estrogen administration correlate positively to the cell nuclear estrogen receptor concentrations. 6These data seem to question the use of cell cytoplasmic estrogen receptor "positiveness" as a sole indicator of the estrogenic status of the tumor or possible involvement of estrogen in tumor growth, and it has become necessary to assess the steroid receptor positiveness in both nuclear and cytoplasmic compartments. The procedure described in this paper has been adopted and modified from a recently developed method for measuring estrogen receptors in rat hypothalamus16 and has several advantages; (1) The ability to determine cytoplasmic and nuclear estrogen and progestin receptors simultaneously. This can also be achieved by the conventional method21but it is laborious and requires several steps involving centrifugation and washing that make receptor loss inevitable, especially when starting tissue weight is less than a gram. (2) Rapidity. From tissue homogenization to the beginning of incubation requires no more than120minutes
and thus reduces the chances of receptor loss during preparation and increases the number of samples that can be handled in a day. (3) Low nonspecific binding. Direct incubation of purified nuclei from tumor tissue with radio-labeled ligand has been reported to have high (ca. 30%) nonspecific binding.12The extraction of nuclear receptors with salt15reduced the nonspecific binding to less than10%, thereby increasing the assay sensitivity.
Several animal studies have indicated that a considerable portion of the nuclear receptors are not extractable with high concentrations of salt and are closed associated with the nuclear matrix.22In the present study, this portion was estimated at about 22%. However, this residual binding which can be solubulized with urea-NaCl had higher nonspecific/specific bound ratio (ca. 4/1) than the initial KCl extracted binding (ca. 1/9) which could obliterate a reliable estimation of the specific receptor binding fraction. Therefore it would be appropriate to limit the vigorous solubilization in those cases with high nuclear receptor levels. When cytoplasmic estrogen receptor concentrations are low, it may reflect two entirely opposite conditions: either poor tissue response or refractoriness to estrogen or a nuclear receptor dominance as a consequence of increased translocation. The latter is a false negative interpretation of tissue receptor "positiveness" and in fact this seems to occur not infrequently because the present data showed that some of the cancerous tissues with lower cytoplasmic estrogen receptors had higher nuclear receptor concentrations.
This does not seem due to a greater nuclear/cytoplasm volume ratio in the cancerous specimen because some nonmalignant tissues included in the present study also showed low cytoplasmic estrogen receptors with high nuclear receptor accumulation (patient K. G.).
This reversed relationship between cytoplasmic and nuclear estrogen receptor levels has also been suggested in a recent study of Schwartz, et al. in which74cases of epithelial ovarian malignancies were studied for the cytoplasmic estrogen and progestin receptors. Among55materials with positive cytoplasmic estrogen or progestin bindings, 23 (42%) had low or barely detectable cytoplasmic estrogen receptors but high progestin receptors (Schwartz et al., unpnblished data). Since high progestin binding indicates an active estrogenic effects, these tissues were likely to have had significant nuclear estrogen accumulation. Another reports from Vihko's laboratory13 also demonstrated that in endometrial carcinoma, the ratio of cytoplasmic and nuclear receptor concentrations significantly lower than that in intact endometrium due to a rise in nuclear receptor levels.
Our data confirmed the presence of et al. 
